B of A Securities Downgrades Privia Health Gr to Neutral, Lowers Price Target to $21
Portfolio Pulse from Benzinga Newsdesk
B of A Securities analyst Adam Ron downgraded Privia Health Group (PRVA) from Buy to Neutral and reduced the price target from $27 to $21.

February 22, 2024 | 2:32 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Privia Health Group was downgraded by B of A Securities from Buy to Neutral with a price target reduction from $27 to $21.
Analyst downgrades typically lead to a negative short-term impact on the stock price as they reflect a less optimistic view on the company's future performance. The reduction in the price target further emphasizes the analyst's lowered expectations for the stock, likely leading to decreased investor confidence and a potential decrease in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100